Combating Cult Mind Control

How can we help individuals who are under undue influence or authoritative control?

Learn More at the 2022 APA Annual Meeting

Dr Hassan and colleagues Karen B. Rosenbaum, MD; Susan Hatters-Friedman, MD; Ryan C. Hall, MD; and Cathleen Cerny-Suelzer, MD, share more about these issues in their session, “The BITE of Cults in Our Culture in the Age of COVID” during the American Psychiatric Association Annual Meeting on Sunday, May 22, 2022. The presentation features an explanation of the BITE Model of Authoritarian Control and why it is particularly important in the COVID era for psychiatrists to take an active role in helping individuals under undue influence or authoritative/exploitative control.

What is undue influence? How do cults and predators operate? And how can clinicians help individuals who are under undue influence or authoritative control, or in exploitative situations? In this episode of An Appointment With, Erin O’Brien, senior editor for Psychiatric Times™, interviews Steven Hassan, PhD, about the importance of effectively evaluating undue influence in the law and clinical settings, and how the BITE (Behavior, Information, Thought, and Emotion) Model of Authoritarian Control can help.

Dr Hassan is a mental health professional and expert working for over 45 years in the field of destructive authoritarian control (undue influence) in relationships, organizations, and belief systems. He is the author of 4 books including Combating Cult Mind Control and Freedom of Mind. He founded the Freedom of Mind Resource Center. He is the developer of the BITE Model of Authoritarian Control, the Influence Continuum Model, and the Strategic Interactive Approach. All are instrumental in helping empower individuals to exit authoritarian cults, trafficking, extremist groups, conspiracy theories, and controlling relationships.

Related Videos
“What we’re striving to do is conquer the unmet needs that are still here with treating ADHD, especially from a medication standpoint.”
Work takes up one-third of a patient’s life—it is important that we pay attention to it.
A new treatment in development is poised to be a game-changer for patients with postpartum depression.
An expert discusses the latest on EndeavorRx and more digital therapeutics for this patient population.
© 2023 MJH Life Sciences

All rights reserved.